BDBM412191 US10398703, Compound 14::US10966987, Compound 14

SMILES COc1cc2c(Oc3ccc(NC(=O)c4cc(C)nn4C)c(Cl)c3)ncnc2cc1OCCCN1CCC2(COC2)CC1

InChI Key InChIKey=RXMTUOGVYMMOLS-UHFFFAOYSA-N

Data  2 Kd

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 412191   

TargetVascular endothelial growth factor receptor 2(Human)
Kala Pharmaceuticals

US Patent
LigandPNGBDBM412191(US10398703, Compound 14 | US10966987, Compound 14)
Affinity DataKd:  3.70E+4nMAssay Description:A VEGFR2 tagged T7 phage strain was prepared in an Escherichia coli (E. coli) derived from the BL21 strain. The E. coli were grown to log-phase, infe...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
10/9/2021
Entry Details
US Patent

TargetVascular endothelial growth factor receptor 2(Human)
Kala Pharmaceuticals

US Patent
LigandPNGBDBM412191(US10398703, Compound 14 | US10966987, Compound 14)
Affinity DataKd:  3.70E+4nMAssay Description:A competition binding assay (DISCOVERX KINOMESCAN ) was used to measure the ability of a compound to compete for binding of an immobilized adenosine ...More data for this Ligand-Target Pair
Ligand InfoSimilars
In Depth
Date in BDB:
7/27/2020
Entry Details
US Patent